Real-world efficacy of ramucirumab plus paclitaxel with or without nivolumab in advanced gastric and gastroesophageal junction cancers. Ann Med Res [Internet]. 2026 Mar. 25 [cited 2026 Mar. 30];33(3):091-8. Available from: http://www.annalsmedres.org/index.php/aomr/article/view/4905